Combined medical surgical therapy for pulmonary mucormycosis in a diabetic renal allograft recipient
- PMID: 11728997
- DOI: 10.1053/ajkd.2001.29293
Combined medical surgical therapy for pulmonary mucormycosis in a diabetic renal allograft recipient
Abstract
Mucormycosis is a rare opportunistic infection that complicates chronic debilitating diseases and immunosuppressed solid-organ transplant recipients. We present a case of life-threatening pulmonary mucormycosis in a diabetic renal allograft recipient who survived with reasonable renal function. Early recognition of this entity and prompt use of bronchoalveolar lavage (BAL) are critical to the outcome. Antifungal therapy combined with early surgical excision of infected, necrotic tissue appears to be the preferred course of action. Judicious withholding of immunosuppressants until fungemia cleared did not jeopardize allograft function.
Similar articles
-
Pulmonary mucormycosis in diabetic renal allograft recipients.Am J Kidney Dis. 1997 Mar;29(3):461-4. doi: 10.1016/s0272-6386(97)90211-0. Am J Kidney Dis. 1997. PMID: 9041226 Review.
-
Pulmonary Rhizopus infection in a diabetic renal transplant recipient.Clin Transplant. 2000 Feb;14(1):8-10. doi: 10.1034/j.1399-0012.2000.140102.x. Clin Transplant. 2000. PMID: 10693628
-
Successful eradication of mucormycosis occurring in a pulmonary allograft.J Heart Lung Transplant. 1999 Aug;18(8):801-4. doi: 10.1016/s1053-2498(99)00033-9. J Heart Lung Transplant. 1999. PMID: 10512529
-
Monster Lung Cavity in a Heart Transplant Recipient.Heart Surg Forum. 2018 Mar 5;21(2):E072-E074. doi: 10.1532/hsf.1922. Heart Surg Forum. 2018. PMID: 29658861
-
Pulmonary mucormycosis: results of medical and surgical therapy.Ann Thorac Surg. 1994 Apr;57(4):1044-50. doi: 10.1016/0003-4975(94)90243-7. Ann Thorac Surg. 1994. PMID: 8166512 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources